These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2525973)
1. Levels of atrial natriuretic peptide are not always consistent with atrial pressure: is there alternative regulation as evidenced in Gordon's and Bartter's syndromes? Klemm SA; Gordon RD; Tunny TJ; Hawkins PG; Finn WL; Hamlet SM; Kewal NK; Purton KJ Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):269-74. PubMed ID: 2525973 [TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man. Klemm SA; Tunny TJ; Gordon RD J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of atrial natriuretic peptide in man in primary aldosteronism, in Gordon's syndrome and in Bartter's syndrome. Tunny TJ; Higgins BA; Gordon RD Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):341-5. PubMed ID: 2942327 [TBL] [Abstract][Full Text] [Related]
4. Effects of posture and saline infusion on atrial natriuretic peptide and haemodynamics in patients with Bartter's syndrome and healthy controls. Doorenbos CJ; Daha MR; Bühler FR; Van Brummelen P Eur J Clin Invest; 1988 Aug; 18(4):369-74. PubMed ID: 2971546 [TBL] [Abstract][Full Text] [Related]
5. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man. Gordon RD; Tunny TJ; Klemm SA; Hamlet SM J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391 [TBL] [Abstract][Full Text] [Related]
6. Altering angiotensin levels by administration of captopril or indomethacin, or by angiotensin infusion, contributes to an understanding of atrial natriuretic peptide regulation in man. Klemm SA; Gordon RD; Tunny TJ; Hamlet SM Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):349-55. PubMed ID: 2978745 [TBL] [Abstract][Full Text] [Related]
7. Plasma atrial natriuretic peptide in primary aldosteronism (before and after treatment) and in Bartter's and Gordon's syndromes. Tunny TJ; Gordon RD Lancet; 1986 Feb; 1(8475):272-3. PubMed ID: 2868281 [No Abstract] [Full Text] [Related]
8. [Elevated atrial natriuretic peptide (ANP) levels and normotension in Bartter's syndrome in childhood]. Di Pietro A; Proverbio MR; Capuano F; Chianese F; Coletta S; Catera P Pediatr Med Chir; 1993; 15(3):289-90. PubMed ID: 8415177 [TBL] [Abstract][Full Text] [Related]
9. Role of prostaglandins in the pathogenesis of Bartter's syndrome. Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488 [TBL] [Abstract][Full Text] [Related]
10. Effects of volume expansion and contraction on plasma levels of atrial natriuretic peptide in man. Finn WL; Gordon RD; Tunny TJ; Klemm SA; Hamlet SM Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):311-5. PubMed ID: 2978743 [TBL] [Abstract][Full Text] [Related]
11. Ageing and blood pressure regulation: dose-response relationships for angiotensin, blood pressure, atrial natriuretic peptide and aldosterone in normal subjects of varying ages. Finn WL; Tunny TJ; Klemm SA; Ryan SJ; Gordon RD Clin Exp Pharmacol Physiol; 1993 May; 20(5):392-4. PubMed ID: 8324930 [TBL] [Abstract][Full Text] [Related]
12. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors. Rudin A; Aurell M; Hansson L; Westberg G Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300 [TBL] [Abstract][Full Text] [Related]
13. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome. Vierhapper H; Waldhäusl W Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358 [TBL] [Abstract][Full Text] [Related]
14. Hypokalemia, in Bartter's syndrome and other disorders, produces resistance to vasopressors via prostaglandin overproduction. Radfar N; Gill JR; Bartter FC; Bravo E; Taylor AA; Bowden RE Proc Soc Exp Biol Med; 1978 Jul; 158(3):502-7. PubMed ID: 684024 [No Abstract] [Full Text] [Related]
15. Dynamic changes in plasma inactive renin levels in Bartter's syndrome after administration of captopril and angiotensin II. Nagai H; Matsunaga M; Ogawa K; Pak CH; Kanatsu K; Hara A; Kono T; Kawai C Clin Exp Pharmacol Physiol; 1986 Jan; 13(1):69-75. PubMed ID: 3519017 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandins and systolic blood pressure, but not angiotensin II, independently affect atrial natriuretic peptide levels in man. Klemm SA; Gordon RD; Tunny TJ; Finn WL; Hornych A Clin Exp Pharmacol Physiol; 1992 May; 19(5):323-6. PubMed ID: 1387841 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome. Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684 [TBL] [Abstract][Full Text] [Related]
18. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831 [TBL] [Abstract][Full Text] [Related]